Chief Medical Officer (CMO)
About the Company
Well-funded early-stage biotech company
Industry
Biotechnology
Type
Privately Held
About the Role
The Company is seeking a Chief Medical Officer (CMO) to join its mission-driven leadership team. The CMO will be responsible for defining and leading the clinical development strategy of the company's oncology radiopharmaceutical portfolio, with a focus on early-phase clinical trials. This role requires a strategic and hands-on leader with a medical degree, preferably with a background in oncology, nuclear medicine, or radiology, and at least 10-15 years of experience in clinical development, particularly in early-phase oncology trials. The successful candidate will act as the senior medical voice on the executive team, influencing strategic decisions and portfolio direction, and will be expected to have a proven track record in early-stage biotech, from IND to clinical proof-of-concept.
Key responsibilities for the CMO include designing, overseeing, and interpreting early-phase clinical studies, providing medical oversight for clinical protocols, safety, and data analysis, and leading the preparation and submission of key regulatory documents. The role also involves building and managing relationships with CROs, investigators, and trial sites, as well as collaborating with global regulatory agencies. The ideal candidate will be a strong communicator with credibility across scientific, regulatory, and investor audiences, and will be expected to promote a culture of agility, transparency, and scientific excellence within the medical function. Experience in radiopharmaceuticals, molecular imaging, or targeted therapies is highly desirable, and the CMO will be a visible and credible ambassador for the company's clinical and scientific vision.
Travel Percent
Less than 10%
Functions
Chief Medical Officer • Dallas, TX, United States